Integra LifeSciences IART Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's deferred tax assets?
- Integra LifeSciences (IART) reported deferred tax assets of $68.08M in Q1 2026.
- How has Integra LifeSciences's deferred tax assets changed year-over-year?
- Integra LifeSciences's deferred tax assets increased by 79.1% year-over-year, from $38.01M to $68.08M.
- What is the long-term trend for Integra LifeSciences's deferred tax assets?
- Over 5 years (2020 to 2025), Integra LifeSciences's deferred tax assets has grown at a -1.1% compound annual growth rate (CAGR), from $73.69M to $69.85M.
- What does deferred tax assets mean?
- Represents future tax benefits arising from temporary differences between the book value of assets/liabilities and their tax basis, or from carry-forward tax losses. These assets are realized when the firm generates sufficient taxable income to offset these differences. It serves as an indicator of future tax savings potential.